Neuroscience

Early treatment tied to less disability with pediatric-onset MS

(HealthDay)—Timing of treatment start is an important predictor of disability accumulation in patients with pediatric-onset multiple sclerosis (MS), according to a study published online Jan. 17 in Multiple Sclerosis and ...

Neuroscience

Fingolimod cuts multiple sclerosis relapses in pediatric patients

(HealthDay)—Among pediatric patients with relapsing multiple sclerosis, fingolimod is associated with a lower rate of relapse but a higher rate of serious adverse events than interferon beta-1a, according to a study published ...

Neuroscience

Obesity may increase risk of MS in children and teens

Being obese may increase the risk of developing multiple sclerosis (MS) in children and teenage girls, according to new research published in the January 30, 2013, online issue of Neurology.

page 1 from 2